Effects of Once-Weekly Subcutaneous Semaglutide on Kidney Function and Safety in T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effects of Once-Weekly Subcutaneous Semaglutide on Kidney Function and Safety in Patients With Type 2 Diabetes: A Post-Hoc Analysis of the SUSTAIN 1-7 Randomised Controlled Trials
Lancet Diabetes Endocrinol 2020 Sep 21;[EPub Ahead of Print], JFE Mann, T Hansen, T Idorn, LA Leiter, SP Marso, P Rossing, J Seufert, S Tadayon, T VilsbøllFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.